As expected, reactivation of Akt enforced an increase of phosphorylated Akt and markedly reversed OXI-induced LC3 turnover and LC3B puncta in OXI treated CRC cells (Fig. S3B-D). The gene discussed is MAP1LC3B; the disease is colorectal carcinoma.